Beyond The Numbers: 4 Analysts Discuss Prestige Consumer Stock
Correction to Premium Brands Holdings Rating
CORRECTION: RBC Capital Maintains Sector Perform on Premium Brands Hldgs, Raises Price Target to C$97 (Stock Name Change From Prestige Consumer (NYSE:PBH) To (TSX: PBH) Premium Brands Holdings.
Express News | CORRECTION: RBC Capital Maintains Sector Perform on Premium Brands Hldgs, Raises Price Target to C$97 (Stock Name Change From Prestige Consumer (NYSE:PBH) To (TSX: PBH) Premium Brands Holdings
Express News | RBC Capital Maintains Sector Perform on Prestige Consumer, Raises Price Target to $97
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt
Earnings Scheduled For March 21, 2025
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Top Executive Sells Thousands of Prestige Consumer Healthcare Shares!
William Blair Initiates Prestige Consumer Healthcare(PBH.US) With Buy Rating
Prestige Consumer Healthcare: Undervalued Growth Potential With Strong Financial Performance and Shareholder Return Prospects
Investing in Prestige Consumer Healthcare (NYSE:PBH) Five Years Ago Would Have Delivered You a 116% Gain
Prestige Consumer Healthcare Insider Sold Shares Worth $959,271, According to a Recent SEC Filing
Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $93
Express News | Prestige Consumer Healthcare Inc : Oppenheimer Raises Target Price to $93 From $87
Eye Drops and Lubricants Market Report 2025-2033, With Profiles of Alcon, Allergan, Bayer, Maya Biotech, Prestige Consumer Healthcare, Rohto Pharmaceutical, Sager Pharma, Similasan & More
D.A. Davidson Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $104
D.A. Davidson Sticks to Their Buy Rating for Prestige Consumer Healthcare (PBH)
Earnings Beat: Prestige Consumer Healthcare Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models